Trial NL84913.000.23

Trial NL84913.000.23 - NL84913.000.23

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON56319

Enrollment

Registered

2023-11-30

Start date

2024-04-15

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer

Interventions

Publication withdrawn by sponsor.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Publication withdrawn by sponsor.

Exclusion criteria

Exclusion criteria: Publication withdrawn by sponsor.

Design outcomes

Primary

Measure	Time frame
Publication withdrawn by sponsor.	—

Secondary

Measure	Time frame
Publication withdrawn by sponsor.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)